Cutaneous T-Cell Lymphoma (CTCL)

Cutaneous T-Cell Lymphoma (CTCL) is the indication for 6 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as: Cutaneous T-Cell Lymphoma · Cutaneous T Cell Lymphoma · Cutaneous T Cell Lymphoma (CTCL) · Cutaneous T Cell Lymphomas (CTCL) · CTCL
Classified under: Hematologic Neoplasms
Skin and Subcutaneous Tissue Diseases
Viral Diseases
Indicated drugs: Cladribine
Gemcitabine
Interferon alfa-2a
Methoxsalen
Pralatrexate
Romidepsin

Resolves to

Vocabularies

MeSHT049119SNOMED CT1162973007MedDRA10011677UMLSC0079773

What you can answer from here — as of October 23, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

193Clinical trialsPhase, status and sponsor resolved per trial

5Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Cutaneous T-Cell Lymphoma (CTCL) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.